# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Hemingway (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET003-SYN-TD
- Date: 1955-07-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Walter Brandt-Ochoa, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Mr. Hemingway is a 56-year-old writer with hereditary hemochromatosis on weekly phlebotomy, severe alcohol use disorder with no alcohol for about two months, depression on sertraline 100 mg, hypertension on amlodipine 10 mg, post-concussion symptoms and prediabetes, who comes for his yearly preventive visit seven weeks after his fourteen-week review. His hand healed fully after the antibiotics. He has had seventeen phlebotomy sessions so far, with the eighteenth today, and tolerates them well. He has had no alcohol since he chose to stop, takes naltrexone daily, and has fewer cravings. His mood is better and his PHQ-9 today is 6. His home blood pressure average is 126/78. He has headaches about once a week and is writing every morning again. His guns remain in the locked storage at his shooting club. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 56 |
| Alcohol | None for about two months |
| Phlebotomy | Seventeen sessions; the eighteenth today; tolerated well |
| Mood | PHQ-9 6; item 9 scored 0 |
| Medicines | Naltrexone 50 mg, sertraline 100 mg, amlodipine 10 mg and thiamine 100 mg daily |

## Health risk assessment

Completed by the patient on paper in the waiting room and reviewed with him by Dr. Brandt-Ochoa. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than in the spring |
| Psychosocial | Weekly psychotherapy; writing every morning; close friends from fishing and hunting |
| Substance use | No alcohol for about two months; no other drugs |
| Tobacco | Does not smoke |
| Physical activity | Swims most days and walks; back stiffness limits long walks |
| Nutrition | Eats fish and vegetables; no iron or vitamin C supplements; no raw shellfish |
| Sleep | Six to seven hours on most nights |
| Hearing and vision | Some hearing loss in noisy rooms after years of shooting; reads with glasses |
| Safety at home | Feels safe at home; firearms stored off-site at his shooting club |
| Road and water safety | Wears a seat belt; wears a life jacket on the boat in rough weather |
| Activities of daily living | Independent |
| Oral health | Dental visit in the past year |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or night sweats; weight down 4 kg since the spring, as he wished |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Positive | Some difficulty hearing in noisy rooms; no ear pain |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain, blood in the stool or change in bowel habit |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Positive | Lower back stiffness since the crashes; no new joint pain |
| Integumentary | Negative | Hand wound healed; no new skin lesions |
| Neurological | Positive | Headaches about once a week; no weakness or numbness |
| Psychiatric | Negative | Mood better; PHQ-9 6; no thoughts of suicide or self-harm |

11 systems reviewed. **S**

## Current medications

- Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinking **S**
- Thiamine 100 mg oral tablet, one tablet daily **S**
- Sertraline 100 mg oral tablet, one tablet daily **S**
- Amlodipine 10 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/80 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 93.6 kg; BMI 27.9 kg/m². All vital signs are synthetic.

PHQ-9: 6. All results are synthetic.

## Change since baseline

- PHQ-9: 16 at baseline, 6 at this visit **S**

## Immunizations given today

- Pneumococcal conjugate vaccine (PCV20), one dose for chronic liver disease and alcohol use disorder **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**
- Hepatitis A and hepatitis B vaccine, dose 1 of 3, for chronic liver disease after nonreactive hepatitis B tests **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 93.6 kg, BMI 27.9; blood pressure 128/80; pulse 74 |
| Eyes | Pupils equal and reactive; fundi without hypertensive changes |
| Ears | Canals clear; whispered voice test reduced on the right |
| Cardiovascular | Regular rhythm; no murmur |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; liver edge not palpable; no spleen felt |
| Skin | Hand healed; sun damage on the face and forearms without a suspicious lesion; no bronze pigmentation |
| Musculoskeletal | Lumbar movement mildly limited; no joint swelling |
| Psychiatric | Calm and engaged; good humor |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated. HIV, hepatitis C and hepatitis B tests at intake were nonreactive. Colorectal cancer screening is due. **S**
   - Colonoscopy ordered.
   - Pneumococcal, zoster and hepatitis A and B vaccines today.
   - Audiology hearing test offered for hearing loss after years of shooting.
   - Next preventive visit in one year.
2. **Alcohol use disorder, severe, in early remission** (F10.20). No alcohol for about two months on naltrexone. Safety reviewed: no thoughts of suicide or self-harm; firearms remain stored off-site; he has the 988 Suicide & Crisis Lifeline in his phone. **S**
   - Continue naltrexone 50 mg daily.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 128/80 mmHg on treatment; home average 126/78 |
| Colorectal cancer screening | Ordered | Ages 45 to 75; no screening before; colonoscopy ordered |
| Prostate cancer screening | Declined | Shared decision-making for ages 55 to 69; he chose not to have a PSA test this year |
| Lung cancer screening | Not indicated | Never a cigarette smoker |
| Diabetes screening | Up to date | HbA1c 6.1% at intake (prediabetes); repeat at the six-month visit |
| Statin for primary prevention | Due | Estimated 10-year cardiovascular risk about 7% at intake; lipids to be repeated at the six-month visit after months without alcohol, then a shared decision |
| HIV screening | Up to date | Nonreactive at intake |
| Hepatitis C screening | Up to date | Antibody nonreactive at intake |
| Hepatitis B screening | Up to date | Triple panel nonreactive at intake; not immune, so vaccination started |
| Depression screening | Completed today | PHQ-9 6, from 16 at intake; item 9 scored 0; in treatment |
| Unhealthy alcohol use | Up to date | AUDIT 26 at intake; in treatment; no alcohol for about two months |
| Tobacco use | Completed today | Does not smoke |
| Pneumococcal vaccine | Completed today | PCV20 today for chronic liver disease and alcohol use disorder |
| Zoster vaccine | Completed today | Recombinant vaccine dose 1 of 2; dose 2 in two to six months |
| Hepatitis A and B vaccines | Completed today | Combined vaccine dose 1 of 3, for chronic liver disease |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap at the sick visit in the spring |
| Influenza vaccine | Due | Next season's vaccine in the autumn |

## Advance care planning

Voluntary advance care planning discussion of about 18 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think clearly and write, and being outdoors. He chose not to record specific treatment preferences today and asked to return to the subject when his treatment is further along. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Six-month review in five weeks with iron studies, liver tests, HbA1c, lipids and the repeat MoCA. Weekly phlebotomy continues. Colonoscopy to be scheduled. Second zoster and hepatitis vaccine doses due. Next preventive visit in one year. **S**
- Next scheduled visit 1955-08-31: six-month review: iron, liver, mood, memory and the plan for maintenance phlebotomy. **S**
